| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1009: Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension |
|
Medicine details |
|
| Medicine name | netarsudil mesilate/latanoprost (Roclanda®) |
| Formulation | 50 micrograms/ml + 200 micrograms/ml eye drops |
| Reference number | 2781 |
| Indication | Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction |
| Company | Santen UK Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/05/2021 |
| NICE guidance | |